FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076109 [Registered on: 01/11/2024] Trial Registered Prospectively
Last Modified On: 25/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Non-randomized, Multiple Arm Trial 
Public Title of Study   To check laryngoscopic responses of dexmedetomidine versus magnesium sulphate when given through nasal route as a spray under general anaesthesia. 
Scientific Title of Study   A STUDY TO COMPARE INTRANASAL DEXMEDETOMIDINE VERSUS MAGNESIUM SULPHATE AS AN ATOMIZER ON ATTENUATION OF HAEMODYNAMIC STRESS RESPONSE TO LARYNGOSCOPY UNDER GENERAL ANAESTHESIA 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aditi Gupta 
Designation  Resident doctor 
Affiliation  Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre 
Address  Anaesthesia Department, General Ot Complex,2nd Floor,Dhiraj Hospital, Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre, Waghodiya, Piparia ,Vadodara,GUJARAT,391760 India

Vadodara
GUJARAT
391760
India 
Phone  8095946481  
Fax    
Email  aditig16295@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tejash Sharma 
Designation  Professor 
Affiliation  Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre 
Address  Anaesthesia Department, General Ot Complex ,2nd Floor, Dhiraj Hospital , Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre ,Waghodiya, Piparia ,Vadodara,GUJARAT,391760 India

Vadodara
GUJARAT
391760
India 
Phone  9427332100  
Fax    
Email  drtejashs.sbks@sumandeepvidyapeethdu.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Tejash Sharma 
Designation  Professor 
Affiliation  Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre 
Address  Anaesthesia Department, General Ot Complex ,2nd Floor, Dhiraj Hospital , Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre ,Waghodiya, Piparia ,Vadodara,GUJARAT,391760 India

Vadodara
GUJARAT
391760
India 
Phone  9427332100  
Fax    
Email  drtejashs.sbks@sumandeepvidyapeethdu.edu.in  
 
Source of Monetary or Material Support  
Smt Bhikiben Kanjibhai Shah Medical Institute and Research Centre, Waghodia, Pipariya, Vadodara, Gujarat, India Pincode- 391760 
 
Primary Sponsor  
Name  Smt Bhikiben Kanjibhai Shah Medical Institute and Research Center 
Address  Waghodia, Piparia, Vadodara, Gujarat, India, 391760 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tejash H Sharma  Sumandeeep Vidyapeeth  Dhiraj Hospital, Shrimati Bhikhiben Kanjibhai Shah Medical College and Research centre, Sumandeep Vidyapeeth , Ta Waghodia, Pipariya, Vadodara, Gujarat 391760, India
Vadodara
GUJARAT 
9427332100

drtejashs.sbks@sumandeepvidyapeethdu.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sumandeep Vidyapeeth Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intranasal Dexmedetomidine 2 mcg/kg via atomiser  Alpha 2 agonist, intranasal Dexmedetomidine 2 mcg/kg 30 minutes prior induction via atomiser. 
Comparator Agent  intransal magnesium sulphate 1000 mg via atomiser  intranasal magnesium sulphate 1000 mg through both nostrils 30 minutes prior induction via atomiser 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients willing to sign written and informed consent.
Male or Female patients between 18 to 65 years of age.
Patients belonging to American Society of Anaesthesiologists(ASA) physical status I and II.
Patients posted for elective surgeries under general anesthesia. 
 
ExclusionCriteria 
Details  Patients unwilling to participate in study.
Patients with Body Mass Index greater than 30 Kg per m square.
Patients having arrythmias.
Patient having heart rate less than 70 beats per minute.
Psychiatric patients.
Pregnancy and lactating women.
Patients belonging to the American Society of Anaesthesiologists (ASA) III and above.
Patients allergic to the study drugs.
Serum magnesium level greater than 2.5mEq per l. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare intranasal Dexmedetomidine versus magnesium sulphate as atomiser in attenuating heart
rate and blood pressure during laryngoscopy under general anesthesia 
Haemodynamic responses will be observed at baseline, after test drug administratiion, during induction, during laryngoscopy and intubation and after intubation at 1,3,5,7 and 10 minutes. 
 
Secondary Outcome  
Outcome  TimePoints 
To compare intranasal Dexmedetomidine versus Magnesium sulphate as atomiser for observing post
operative sedation and side effects. 
Post operatively sedation status will be assessed half hourly by RAMSAY Sedation Score (RSS) till a score
of 2 is achieved 
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   06/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 25-10-2025 and end date provided 25-10-2028?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  
A study to compare intranasal Dexmedetomidine versus magnesium sulphate as an atomiser on attenuation of haemodynamic stress response to laryngoscopy under general anaesthesia.
Objective is to study the comparison between Dexmedetomidine and magnesium sulphate that how well it reduces heart rate and blood pressure when given intranasally via atomiser during laryngoscopy under general anaesthesia , to study post operative Ramsay sedation score and to observe if there are any side effects of the given drug.

Inclusion criteria Patients willing to sign written and informed consent, male or female patients between 18 to 65 years of age, patients belonging to American Society of Anaesthesiologists(ASA) physical status I and II, patients posted for elective surgeries under general anaesthesia.

Exclusion criteria
 Patients unwilling to participate in study, patients with Body Mass Index greater than 30 Kg per metre square, patients having arrythmias, patient having heart rate less than 70 beats per minute, psychiatric patients, pregnancy and lactating women, patients belonging to the American Society of Anaesthesiologists (ASA) III and above, patients allergic to the study drugs, serum magnesium level greater than 2.5 meq per litre.

The study will be conducted on 56 adults aged 18 to 60 yrs belonging to grade
I & II of American Society of Anesthesiologists (ASA) classification who will
undergo elective surgeries under general anesthesia. They will be divided
into 2 equal groups with chit method.
Group D will recieve dexmedtomidine 2 mcg per kg in 2ml 0.9 percent NS and Group M will recieve magnesium
sulphate 1000mg in 2ml 0.9 percent NS through atomiser 30 minutes before induction by consultant anaesthesiologist. After completion of
atomisation following vitals will be observed : Heart Rate (HR) , Systolic Blood Pressure (SBP) , Diastolic
Blood Pressure (DBP) , Mean Arterial Pressure (MAP), SpO2 at baseline (Tb) , after test drug administration
(Td), during induction (Ti), during laryngoscopy and intubation (T0) , at 1 , 3 , 5 , 7 and 10 mintues after
intubation (T1), (T3), (T5), (T7), (T10) respectively. Post operatively sedation status will be assessed half hourly by RAMSAY Sedation Score (RSS) till a score
of 2 is achieved.

Site of Study Department of Anesthesiology, Dhiraj Hospital, S.B.K.S.
Medical Institute and Research Centre, Piparia, Waghodia, Vadodara

Study Design Prospective, double blinded and comparative study.

Study Duration  The study will be initiated after obtaining permission from
institutional ethics committee till the achievement of the sample size or by
18 months whichever is earlier.

Statistics Numerical variables will be presented as mean & standard deviation
(SD) while categorical variables will be presented as frequency and
percentage. As regard to numerical variables; tests like unpaired student-t
test and/or ANNOVA will be used wherever appropriate for
between-groups comparisons, while for categorical variables; chi-square
test will be used. P value  less than 0.05 will be considered statistically significant.

Likely outome This prospective and comparative study will help
us to compare the efficacy between intranasal Dexmedetomidine and magnesium sulphate via atomiser in attenuating hemodynamic responses to laryngoscopy in patients undergoing surgeries under general anesthesia by
having better outcome in hemodynamics.
 
Close